• Western blot analysis of extracts of mouse liver, using SSSCA1 antibody (STJ112176) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Anti-SSSCA1 antibody (1-199) (STJ112176)

SKU:
STJ112176

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-SSSCA1 (1-199) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: ZNRD2
Gene ID: 10534
Uniprot ID: ZNRD2_HUMAN
Immunogen Region: 1-199
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-199 of human SSSCA1 (NP_006387.1).
Immunogen Sequence: MALNGAEVDDFSWEPPTEAE TKVLQARRERQDRISRLMGD YLLRGYRMLGETCADCGTIL LQDKQRKIYCVACQELDSDV DKDNPALNAQAALSQAREHQ LASASELPLGSRPAPQPPVP RPEHCEGAAAGLKAAQGPPA PAVPPNTDVMACTQTALLQK LTWASAELGSSTSLETSIQL CGLIRACAEALRSLQQLQH
Function Might play a role in mitosis. Antigenic molecule. Could be a centromere-associated protein. May induce anti-centromere antibodies.
Protein Name Protein Znrd2
Autoantigen P27
Sjoegren Syndrome/Scleroderma Autoantigen 1
Zinc Ribbon Domain-Containing Protein 2
Alternative Antibody Names Anti-Protein Znrd2 antibody
Anti-Autoantigen P27 antibody
Anti-Sjoegren Syndrome/Scleroderma Autoantigen 1 antibody
Anti-Zinc Ribbon Domain-Containing Protein 2 antibody
Anti-ZNRD2 antibody
Anti-SSSCA1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance